Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial)
- Tandjung, K.
- van Houwelingen, K.G.
- Jansen, Hanneke
- Basalus, M.W.Z.
- Sen, H.
- Lowik, M.M.
- Stoel, Martin
- Louwerenburg, J.W.
- De Man, F.H.A.F.
- Linssen, G.C.M.
- Nijhuis, R.
- Nienhuis, M.B.
- van der Palen, J.
- Stolk, R.P.
- von Birgelen, C.
DOIAbstract
In patients without a history of diabetes mellitus, increased levels of glycated hemoglobin (HbA1c) are associated with higher cardiovascular risk. The relation between undetected diabetes and clinical outcome after percutaneous coronary intervention is unknown. To investigate whether these patients may have an increased risk of periprocedural myocardial infarction (PMI), the most frequent adverse event after percutaneous coronary intervention, we assessed patients of the TWENTE trial (a randomized, controlled, second-generation drug-eluting stent trial) in whom HbA1c data were available. Patients were classified as known diabetics or patients without a history of diabetes who were subdivided into undetected diabetics (HbA1c >= 6.5%) and...
Add to ORKG